Showing results (21-30 of 388) with videos related to
Sort By:
Pageof 39
Current Medicinal Chemistry|May 17, 2011
Recent advances in the DABOs family as potent HIV-1 non-nucleoside reverse transcriptase inhibitorsMingyan Yu, Erkang Fan, Jingde Wu, et al.Current Medicinal Chemistry|October 30, 2013
Recent advances in the discovery and development of novel HIV-1 NNRTI platforms (Part II): 2009-2013 updateYu'ning Song, Zengjun Fang, Peng Zhan, et al.Frontiers in Chemistry|August 8, 2022
Organic Electroluminescent Materials Possessing Intra- and Intermolecular Hydrogen Bond Interactions: A Mini-ReviewXinyong Liu, Jingwei Li, Xu Qiu, et al.Drug Discovery Today|January 20, 2024
Revolutionizing viral disease treatment: Phase separation and lysosome/exosome targeting as new areas and new paradigms for antiviral drug researchShaoqing Du, Xueping Hu, Xinyong Liu, et al.Journal of Medicinal Chemistry|September 20, 2024
Viral Protein Dimerization Quality Control: A Design Strategy for a Potential Viral InhibitorShaoqing Du, Xinyong Liu, Xueping Hu, et al.European Journal of Medicinal Chemistry|October 14, 2011
Ligustrazine derivatives. Part 5: design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agentsHongfei Chen, Guoning Li, Peng Zhan, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|May 20, 2015
Review of small synthetic molecules targeting HBV capsid assemblyNa Liu, Fabao Zhao, Peng Zhan, et al.Current Pharmaceutical Design|November 8, 2012
Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistryYu'ning Song, Peng Zhan, Qingzhu Zhang, et al.Expert Opinion on Therapeutic Patents|January 9, 2016
Substituted indoles as HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent evaluation (WO2015044928)Xiao Li, Ping Gao, Peng Zhan, et al.Expert Opinion on Drug Discovery|September 16, 2015
Fragment-based approaches to anti-HIV drug discovery: state of the art and future opportunitiesBoshi Huang, Dongwei Kang, Peng Zhan, et al.Pageof 39